OWLT

SEC source: 0001628280-23-023197 · wk-form4_1687483264.xml · nonDerivative · entry 1

Scolnick Kathryn R. · CIK 0001749118 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 481,069

F1 · kind: The sales reported on this Form 4 represent shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units.

SEC source: 0000899243-22-015120 · doc4.xml · nonDerivative · entry 1

Abbott Michael P. · CIK 0001868401 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 544,060

F1 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on April 15, 2023, subject to the Reporting Person's continued service to the Issuer through such vesting date.

SEC source: 0000899243-22-015114 · doc4.xml · nonDerivative · entry 1

Scolnick Kathryn R. · CIK 0001749118 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 466,840

F1 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on April 15, 2023, subject to the Reporting Person's continued service to the Issuer through such vesting date.

SEC source: 0000899243-22-015116 · doc4.xml · nonDerivative · entry 1

Workman Kurt · CIK 0001868338 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,909,583

F1 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on April 15, 2023, subject to the Reporting Person's continued service to the Issuer through such vesting date.

F2 · balance_after: Amount beneficially owned following the transaction reported herein based on the Reporting Person's Form 4 filed on March 25, 2022 and reflecting RSUs granted on March 14, 2022.

SEC source: 0000899243-22-011584 · doc4.xml · nonDerivative · entry 1

Workman Kurt · CIK 0001868338 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,117,349

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.72 to $2.90. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000899243-22-011223 · doc4.xml · nonDerivative · entry 1

Workman Kurt · CIK 0001868338 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,101,023

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.28 to $2.35. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000899243-22-012328 · doc4.xml · nonDerivative · entry 1

Workman Kurt · CIK 0001868338 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,906,823

F1 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs shall vest on the one-year anniversary of March 15, 2022, and 1/16th of the total number of RSUs shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0000899243-22-012329 · doc4.xml · nonDerivative · entry 1

Abbott Michael P. · CIK 0001868401 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 526,316

F1 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs shall vest on the one-year anniversary of March 15, 2022, and 1/16th of the total number of RSUs shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0000899243-22-012330 · doc4.xml · nonDerivative · entry 1

Scolnick Kathryn R. · CIK 0001749118 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 457,639

F1 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs shall vest on the one-year anniversary of March 15, 2022, and 1/16th of the total number of RSUs shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0000899243-22-010968 · doc4.xml · nonDerivative · entry 2

Workman Kurt · CIK 0001868338 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,085,854

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.21 to $2.25. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000899243-22-010968 · doc4.xml · nonDerivative · entry 1

Workman Kurt · CIK 0001868338 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,083,702

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.14 to $2.25. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0000899243-22-006949 · doc4.xml · derivative · entry 2

Yoo Nathaniel · CIK 0001908778 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,909

Underlying: Common Stock · 79,909 shares

Expires 2032-02-15

F2 · derivative.exercise_date: 25% of the shares subject to the option shall vest on the one-year anniversary of January 10, 2022, and 1/36th of the remaining 75% of the shares subject to the option shall vest in equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer though the applicable vesting date.

SEC source: 0000899243-22-006949 · doc4.xml · nonDerivative · entry 1

Yoo Nathaniel · CIK 0001908778 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,726

F1 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs shall vest on the one-year anniversary of February 15, 2022, and 1/12th of the remaining 75% of the RSUs shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

SEC source: 0001567619-21-020692 · doc1.xml · derivative · entry 2

Scolnick Kathryn R. · CIK 0001749118 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 247,113

Underlying: Common Stock · 247,113 shares

Expires 2031-11-15

F3 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from March 15, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

SEC source: 0001567619-21-020692 · doc1.xml · nonDerivative · entry 1

Scolnick Kathryn R. · CIK 0001749118 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 247,113

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs shall vest on the one year anniversary of February 15, 2021 (the "Vesting Commencement Date"), and 1/16th of the total number RSUs vest quarterly thereafter, subject to the Reporting Person's continued service to the issuer.

F2 · balance_after: Includes 247,113 RSUs.

SEC source: 0001567619-21-020691 · doc1.xml · nonDerivative · entry 1

Durr Laura · CIK 0001319799 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,120

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the one year anniversary of February 22, 2021, subject to the Reporting Person's continued service to the issuer.

F2 · balance_after: Includes 32,120 RSUs.

SEC source: 0001567619-21-020688 · doc1.xml · nonDerivative · entry 1

BURKE ZANE M · CIK 0001213555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,779

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the one year anniversary of March 12, 2021, subject to the Reporting Person's continued service to the issuer.

F2 · balance_after: Includes 32,120 RSUs.

SEC source: 0001567619-21-020690 · doc1.xml · nonDerivative · entry 1

Kim John C. · CIK 0001868479 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,120

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the one year anniversary of April 30, 2021, subject to the Reporting Person's continued service to the issuer.

F2 · balance_after: Includes 32,120 RSUs.

SEC source: 0001140361-21-024844 · form4.xml · nonDerivative · entry 1

BURKE ZANE M · CIK 0001213555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,659

F1 · price: On July 15, 2021, pursuant to that certain Business Combination Agreement, dated as of February 15, 2021, by and among the Issuer, Project Olympus Merger Sub, Inc. ("Merger Sub") and Owlet Baby Care Inc. ("Owlet Baby Care"), Merger Sub merged with and into Owlet Baby Care with Owlet Baby Care surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each issued and outstanding share of common stock of Owlet Baby Care was automatically cancelled and converted into approximately 2.053 (the "Exchange Ratio") shares of common stock of the Issuer.

SEC source: 0001140361-21-024843 · form4.xml · nonDerivative · entry 2

Susan Lior · CIK 0001832895 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 14,930,616

F1 · price: On July 15, 2021, pursuant to that certain Business Combination Agreement, dated as of February 15, 2021, by and among the Issuer, Project Olympus Merger Sub, Inc. ("Merger Sub") and Owlet Baby Care Inc. ("Owlet Baby Care"), Merger Sub merged with and into Owlet Baby Care with Owlet Baby Care surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each issued and outstanding share of common stock of Owlet Baby Care was automatically cancelled and converted into approximately 2.053 (the "Exchange Ratio") shares of common stock of the Issuer.

F3 · ownership.nature: The shares of common stock are held of record by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity I"). Eclipse Continuity GP I, LLC ("Eclipse Continuity GP") is the general partner of Eclipse Continuity I and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. The reporting person is the sole managing member of Eclipse Continuity GP and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. Eclipse Continuity GP and the reporting person disclaim beneficial ownership of the shares held by Eclipse Continuity I except to the extent of their respective pecuniary interests therein, if any.

SEC source: 0001140361-21-024843 · form4.xml · nonDerivative · entry 1

Susan Lior · CIK 0001832895 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 13,561,716

F1 · price: On July 15, 2021, pursuant to that certain Business Combination Agreement, dated as of February 15, 2021, by and among the Issuer, Project Olympus Merger Sub, Inc. ("Merger Sub") and Owlet Baby Care Inc. ("Owlet Baby Care"), Merger Sub merged with and into Owlet Baby Care with Owlet Baby Care surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each issued and outstanding share of common stock of Owlet Baby Care was automatically cancelled and converted into approximately 2.053 (the "Exchange Ratio") shares of common stock of the Issuer.

F2 · ownership.nature: The shares of common stock are held of record by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. The reporting person is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and the reporting person disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.

SEC source: 0001140361-21-024842 · form4.xml · derivative · entry 2

Workman Kurt · CIK 0001868338 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,473

Underlying: Common Stock · 339,473 shares

Expires 2031-01-23

F2 · shares: At the Effective Time, each outstanding option to purchase shares of Owlet Baby Care common stock (each an "Owlet Baby Care Option") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer equal to (i) the number of shares of Owlet Baby Care common stock subject to the applicable Owlet Baby Care Option multiplied by (ii) the Exchange Ratio, rounded down to the nearest whole share.

F1 · price: On July 15, 2021, pursuant to that certain Business Combination Agreement, dated as of February 15, 2021, by and among the Issuer, Project Olympus Merger Sub, Inc. ("Merger Sub") and Owlet Baby Care Inc. ("Owlet Baby Care"), Merger Sub merged with and into Owlet Baby Care with Owlet Baby Care surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each issued and outstanding share of common stock of Owlet Baby Care was automatically cancelled and converted into approximately 2.053 (the "Exchange Ratio") shares of common stock of the Issuer.

F3 · derivative.exercise_date: Represents an award of stock options on January 24, 2021, which vests in 48 monthly installments thereafter beginning on February 11, 2021, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0001140361-21-024842 · form4.xml · nonDerivative · entry 1

Workman Kurt · CIK 0001868338 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,074,202

F1 · price: On July 15, 2021, pursuant to that certain Business Combination Agreement, dated as of February 15, 2021, by and among the Issuer, Project Olympus Merger Sub, Inc. ("Merger Sub") and Owlet Baby Care Inc. ("Owlet Baby Care"), Merger Sub merged with and into Owlet Baby Care with Owlet Baby Care surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each issued and outstanding share of common stock of Owlet Baby Care was automatically cancelled and converted into approximately 2.053 (the "Exchange Ratio") shares of common stock of the Issuer.

SEC source: 0001140361-21-024841 · form4.xml · derivative · entry 3

Abbott Michael P. · CIK 0001868401 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 494,226

Underlying: Common Stock · 494,226 shares

Expires 2031-01-23

F1 · shares: On July 15, 2021, pursuant to that certain Business Combination Agreement, dated as of February 15, 2021, by and among the Issuer, Project Olympus Merger Sub, Inc. ("Merger Sub") and Owlet Baby Care Inc. ("Owlet Baby Care"), Merger Sub merged with and into Owlet Baby Care with Owlet Baby Care surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each outstanding option to purchase shares of Owlet Baby Care common stock (each an "Owlet Baby Care Option") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer equal to (i) the number of shares of Owlet Baby Care common stock subject to the applicable Owlet Baby Care Option multiplied by (ii) approximately 2.053, rounded down to the nearest whole share.

F1 · price: On July 15, 2021, pursuant to that certain Business Combination Agreement, dated as of February 15, 2021, by and among the Issuer, Project Olympus Merger Sub, Inc. ("Merger Sub") and Owlet Baby Care Inc. ("Owlet Baby Care"), Merger Sub merged with and into Owlet Baby Care with Owlet Baby Care surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each outstanding option to purchase shares of Owlet Baby Care common stock (each an "Owlet Baby Care Option") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer equal to (i) the number of shares of Owlet Baby Care common stock subject to the applicable Owlet Baby Care Option multiplied by (ii) approximately 2.053, rounded down to the nearest whole share.

F4 · derivative.exercise_date: Represents an award of stock options on January 24, 2021, which vests in 48 monthly installments beginning on January 1, 2021, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0001140361-21-024841 · form4.xml · derivative · entry 2

Abbott Michael P. · CIK 0001868401 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,659

Underlying: Common Stock · 102,659 shares

Expires 2030-03-22

F1 · shares: On July 15, 2021, pursuant to that certain Business Combination Agreement, dated as of February 15, 2021, by and among the Issuer, Project Olympus Merger Sub, Inc. ("Merger Sub") and Owlet Baby Care Inc. ("Owlet Baby Care"), Merger Sub merged with and into Owlet Baby Care with Owlet Baby Care surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each outstanding option to purchase shares of Owlet Baby Care common stock (each an "Owlet Baby Care Option") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer equal to (i) the number of shares of Owlet Baby Care common stock subject to the applicable Owlet Baby Care Option multiplied by (ii) approximately 2.053, rounded down to the nearest whole share.

F1 · price: On July 15, 2021, pursuant to that certain Business Combination Agreement, dated as of February 15, 2021, by and among the Issuer, Project Olympus Merger Sub, Inc. ("Merger Sub") and Owlet Baby Care Inc. ("Owlet Baby Care"), Merger Sub merged with and into Owlet Baby Care with Owlet Baby Care surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each outstanding option to purchase shares of Owlet Baby Care common stock (each an "Owlet Baby Care Option") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer equal to (i) the number of shares of Owlet Baby Care common stock subject to the applicable Owlet Baby Care Option multiplied by (ii) approximately 2.053, rounded down to the nearest whole share.

F3 · derivative.exercise_date: Represents an award of stock options on March 23, 2020, which vests in 48 monthly installments beginning on January 1, 2020, subject to the reporting person's continued service through the applicable vesting date.

SEC source: 0001140361-21-024841 · form4.xml · derivative · entry 1

Abbott Michael P. · CIK 0001868401 · Director · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 823,370

Underlying: Common Stock · 823,370 shares

Expires 2028-03-18

F1 · shares: On July 15, 2021, pursuant to that certain Business Combination Agreement, dated as of February 15, 2021, by and among the Issuer, Project Olympus Merger Sub, Inc. ("Merger Sub") and Owlet Baby Care Inc. ("Owlet Baby Care"), Merger Sub merged with and into Owlet Baby Care with Owlet Baby Care surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each outstanding option to purchase shares of Owlet Baby Care common stock (each an "Owlet Baby Care Option") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer equal to (i) the number of shares of Owlet Baby Care common stock subject to the applicable Owlet Baby Care Option multiplied by (ii) approximately 2.053, rounded down to the nearest whole share.

F1 · price: On July 15, 2021, pursuant to that certain Business Combination Agreement, dated as of February 15, 2021, by and among the Issuer, Project Olympus Merger Sub, Inc. ("Merger Sub") and Owlet Baby Care Inc. ("Owlet Baby Care"), Merger Sub merged with and into Owlet Baby Care with Owlet Baby Care surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each outstanding option to purchase shares of Owlet Baby Care common stock (each an "Owlet Baby Care Option") was automatically cancelled and converted into an option to purchase a number of shares of common stock of the Issuer equal to (i) the number of shares of Owlet Baby Care common stock subject to the applicable Owlet Baby Care Option multiplied by (ii) approximately 2.053, rounded down to the nearest whole share.

F2 · derivative.exercise_date: Represents an award of stock options on March 19, 2018, which vests with respect to 25% of the options on February 26, 2019 and as to the remaining 75% in 36 monthly installments thereafter, subject to the reporting person's continued service through the applicable vesting date.